Logotype for LogicMark Inc

LogicMark (LGMK) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for LogicMark Inc

Q4 2025 earnings summary

25 Mar, 2026

Executive summary

  • Achieved strong revenue and gross profit growth in both Q4 and full year 2025, driven by product innovation, expanded distribution, and disciplined execution.

  • Maintained robust gross margins and ended the year with a healthy cash position and no long-term debt.

  • Transitioned from a hardware-focused company to a broader connected care platform with expanded software, data, and IP capabilities.

  • Expanded product portfolio and deepened market reach, especially in B2B, healthcare, and government channels, supported by a renewed five-year GSA contract.

  • Net loss narrowed to $1.6 million in Q4 from $3.7 million a year ago; full-year net loss improved to $7.5 million from $9.0 million.

Financial highlights

  • Q4 2025 revenue rose 36% year-over-year to $3.1 million; gross profit up 43% to $2.1 million; gross margin improved to 69.8%.

  • Full year 2025 revenue increased 15% to $11.4 million; gross profit up 15% to $7.6 million; gross margin steady at 66.8%.

  • Diluted loss per share was $1.96 for Q4 and $13.06 for the year, reflecting a reverse stock split.

  • Q4 operating expenses increased 3% to $3.8 million; full-year operating expenses rose 9% to $15.5 million, mainly due to higher selling, marketing, and legal costs.

  • Ended 2025 with $9.5 million in cash and investments, $9.7 million in net working capital, and no long-term debt.

Outlook and guidance

  • Expect Q1 2026 revenue to increase 10%-15% year-over-year.

  • Focus remains on expanding distribution across healthcare, government, B2B, and consumer channels in 2026.

  • Ongoing focus on expanding subscription monitoring and digital care features to strengthen recurring revenue.

  • Two new solutions in the pipeline: a wearable watch launching in Q3 2026 and a connected-home hub with AI-powered fall detection.

  • Prioritizing operational leverage, scaling monitored and connected care revenue, and converting R&D investments into commercial outcomes in 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more